AP628A - New applications of lysozyme dimer. - Google Patents

New applications of lysozyme dimer. Download PDF

Info

Publication number
AP628A
AP628A APAP/P/1996/000783A AP9600783A AP628A AP 628 A AP628 A AP 628A AP 9600783 A AP9600783 A AP 9600783A AP 628 A AP628 A AP 628A
Authority
AP
ARIPO
Prior art keywords
use according
lysozyme
group
pharmaceutical composition
lysozyme dimer
Prior art date
Application number
APAP/P/1996/000783A
Other languages
English (en)
Other versions
AP9600783A0 (en
Inventor
Witold Kiczka
Original Assignee
Nika Health Products
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products filed Critical Nika Health Products
Publication of AP9600783A0 publication Critical patent/AP9600783A0/xx
Application granted granted Critical
Publication of AP628A publication Critical patent/AP628A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fish Paste Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
APAP/P/1996/000783A 1995-01-13 1996-01-12 New applications of lysozyme dimer. AP628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95100446 1995-01-13
EP95110638 1995-07-07

Publications (2)

Publication Number Publication Date
AP9600783A0 AP9600783A0 (en) 1996-04-30
AP628A true AP628A (en) 1998-02-27

Family

ID=26138401

Family Applications (2)

Application Number Title Priority Date Filing Date
APAP/P/1996/000783A AP628A (en) 1995-01-13 1996-01-12 New applications of lysozyme dimer.
APAP/P/1997/001024A AP871A (en) 1995-01-13 1996-01-13 New applicants of lysozyme dimer.

Family Applications After (1)

Application Number Title Priority Date Filing Date
APAP/P/1997/001024A AP871A (en) 1995-01-13 1996-01-13 New applicants of lysozyme dimer.

Country Status (38)

Country Link
EP (2) EP0804227B1 (cs)
JP (1) JPH10511974A (cs)
KR (1) KR100420377B1 (cs)
CN (1) CN1090506C (cs)
AP (2) AP628A (cs)
AT (1) ATE218367T1 (cs)
AU (1) AU709620B2 (cs)
BA (1) BA96074A (cs)
BG (1) BG62239B1 (cs)
BR (1) BR9606973A (cs)
CA (1) CA2210091A1 (cs)
CZ (1) CZ293353B6 (cs)
DE (2) DE804227T1 (cs)
DZ (1) DZ1964A1 (cs)
EA (1) EA001462B1 (cs)
EE (1) EE9700154A (cs)
ES (1) ES2109208T1 (cs)
FI (1) FI972943A0 (cs)
GB (1) GB2311724B (cs)
GE (1) GEP20012571B (cs)
GR (1) GR970300047T1 (cs)
HK (1) HK1002060A1 (cs)
HR (1) HRP960014A2 (cs)
HU (1) HU223903B1 (cs)
IL (1) IL116737A (cs)
MA (1) MA23775A1 (cs)
MD (1) MD1633C2 (cs)
MY (1) MY132437A (cs)
NO (1) NO973203L (cs)
NZ (1) NZ298432A (cs)
OA (1) OA10436A (cs)
PL (1) PL185678B1 (cs)
SK (1) SK94297A3 (cs)
SV (1) SV1996000001A (cs)
TN (1) TNSN96004A1 (cs)
TR (1) TR199700633T1 (cs)
UA (1) UA50728C2 (cs)
WO (1) WO1996021463A2 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
WO1999055354A1 (en) * 1998-04-27 1999-11-04 Nika Health Products Limited Fertility improving composition and application thereof
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods
EP2134354A4 (en) * 2007-03-02 2012-03-21 Saint Simeon Lda COMPOSITION AND METHOD FOR THE TREATMENT OF PAPILLOMA VIRUS AND HORSE SARCODES
CN103518978B (zh) * 2013-10-22 2016-01-13 上海艾魁英生物科技有限公司 新型溶菌酶制剂及其制备方法
CN111643655A (zh) * 2013-12-18 2020-09-11 帝斯曼知识产权资产管理有限公司 用于含角蛋白的组织的包含溶菌酶水解物的组合物
CN104585546B (zh) * 2015-01-20 2019-02-05 上海海洋大学 一种促生长抗应激罗非鱼饲料及其制备方法
CN105707509B (zh) * 2016-01-25 2018-12-28 浙江艾杰斯生物科技有限公司 一种用于防治草鱼烂腮病的饲料添加剂
WO2020099556A1 (en) 2018-11-14 2020-05-22 Universiteit Antwerpen Oxidized lysozyme
WO2021021765A1 (en) * 2019-07-26 2021-02-04 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins
CN111657407A (zh) * 2020-05-14 2020-09-15 上海艾魁英生物科技有限公司 提高断奶仔猪非特异性免疫功能的饲料添加剂、其制备方法和应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
EP0181634A2 (en) * 1984-11-14 1986-05-21 Takeda Chemical Industries, Ltd. Synthetic gene for human lysozyme
WO1989011294A1 (en) * 1988-05-26 1989-11-30 Nika Health Care, Inc. Antiviral or antibacterial compound and method of use
WO1991010731A1 (en) * 1990-01-08 1991-07-25 Nika Health Products Ltd. Method of preparing lysozyme dimers
WO1994001127A1 (en) * 1992-07-13 1994-01-20 Nika Health Products Limited Lysozyme dimer and compositions containing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230999A1 (de) * 1982-08-20 1984-02-23 Philips Kommunikations Industrie AG, 8500 Nürnberg Verfahren zur zugriffssteuerung bei einem nachrichtensystem
RU2061496C1 (ru) * 1985-08-02 1996-06-10 Институт общей патологии и экологии человека Средство, стимулирующее эритропоэз
AU1366088A (en) * 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
WO1991010730A1 (en) * 1990-01-08 1991-07-25 Nika Health Products Ltd. Method of preparing ribonuclease dimers
RU2082413C1 (ru) * 1993-06-30 1997-06-27 Нижегородский государственный медицинский институт Способ лечения язвенной болезни двенадцатиперстной кишки
RU2071339C1 (ru) * 1994-07-25 1997-01-10 Щербакова Элеонора Григорьевна Средство для лечения и профилактики дисбактериоза
RU2123345C1 (ru) * 1997-07-31 1998-12-20 Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук Средство для лечения дисбактериоза

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
EP0181634A2 (en) * 1984-11-14 1986-05-21 Takeda Chemical Industries, Ltd. Synthetic gene for human lysozyme
WO1989011294A1 (en) * 1988-05-26 1989-11-30 Nika Health Care, Inc. Antiviral or antibacterial compound and method of use
WO1991010731A1 (en) * 1990-01-08 1991-07-25 Nika Health Products Ltd. Method of preparing lysozyme dimers
WO1994001127A1 (en) * 1992-07-13 1994-01-20 Nika Health Products Limited Lysozyme dimer and compositions containing the same

Also Published As

Publication number Publication date
AU4391696A (en) 1996-07-31
MD1633C2 (ro) 2001-10-31
CN1177303A (zh) 1998-03-25
BA96074A (bs) 1999-08-02
GEP20012571B (en) 2001-11-26
BR9606973A (pt) 1999-01-26
DE804227T1 (de) 1998-04-09
OA10436A (en) 2001-12-07
EP1086703A3 (en) 2001-05-02
IL116737A0 (en) 1996-05-14
FI972943A (fi) 1997-07-11
ES2109208T1 (es) 1998-01-16
DE69621589D1 (de) 2002-07-11
FI972943A0 (fi) 1997-07-11
WO1996021463A3 (en) 1996-09-19
HUP9801689A3 (en) 2000-07-28
NZ298432A (en) 2001-03-30
AU709620B2 (en) 1999-09-02
KR19980701337A (ko) 1998-05-15
MD970244A (en) 1999-05-31
CZ220297A3 (cs) 1998-02-18
MY132437A (en) 2007-10-31
BG101709A (en) 1998-03-31
BG62239B1 (bg) 1999-06-30
IL116737A (en) 2000-02-17
CZ293353B6 (cs) 2004-04-14
CN1090506C (zh) 2002-09-11
HU223903B1 (hu) 2005-03-29
GB2311724B (en) 1999-07-21
NO973203D0 (no) 1997-07-10
GB9714354D0 (en) 1997-09-10
DZ1964A1 (fr) 2002-10-15
GB2311724A (en) 1997-10-08
SK94297A3 (en) 1998-01-14
CA2210091A1 (en) 1996-07-18
MD1633B2 (en) 2001-03-31
TNSN96004A1 (fr) 2005-03-15
NO973203L (no) 1997-07-10
GR970300047T1 (en) 1997-12-31
ATE218367T1 (de) 2002-06-15
EE9700154A (et) 1997-12-15
AP871A (en) 2000-09-10
SV1996000001A (es) 1997-02-17
HUP9801689A2 (hu) 1998-10-28
EP1086703A2 (en) 2001-03-28
PL321546A1 (en) 1997-12-08
EP0804227B1 (en) 2002-06-05
PL185678B1 (pl) 2003-07-31
HRP960014A2 (en) 1997-12-31
EP0804227A2 (en) 1997-11-05
AP9701024A0 (en) 1997-07-31
MA23775A1 (fr) 1996-10-01
TR199700633T1 (xx) 1998-01-21
EA199700101A1 (ru) 1997-12-30
KR100420377B1 (ko) 2004-05-20
WO1996021463A2 (en) 1996-07-18
AP9600783A0 (en) 1996-04-30
UA50728C2 (uk) 2002-11-15
EA001462B1 (ru) 2001-04-23
JPH10511974A (ja) 1998-11-17
HK1002060A1 (en) 1998-07-31

Similar Documents

Publication Publication Date Title
US11203625B2 (en) Compositions including different types of transfer factor
EP0380484B1 (en) Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug
AP628A (en) New applications of lysozyme dimer.
CN105848662A (zh) 杀肿瘤和抗微生物组合物和方法
US6183742B1 (en) Applications of lysozyme dimer
CN1057937C (zh) 溶菌酵素二聚体的新用途及其含有溶菌酵素二聚体的制剂
CN102363040B (zh) 用于粘膜组织的抗微生物肽制剂
JPH07508010A (ja) ＤＮＡウイルス感染の治療のための薬物の製造のための膜翅類昆虫（ｈｙｍｅｎｏｐｔｅｒａ）毒の使用
US20020098171A1 (en) New application of lysozyme dimer
KR101418881B1 (ko) 면역증강, 염증치료 및 통증치료용 수지봉독과 이를 이용한 비경구 투여용 조성물 및 그 제조방법
KR20060038387A (ko) 화학요법을 받고 있는 암 환자를 치료하는 방법
MXPA97005246A (en) New applications of dimero de lisoz
CN102266346B (zh) 一种防治球虫病的药物
US6123937A (en) Applications of lysozyme dimer
RU2279274C2 (ru) Способ профилактики вторичного альвеолярного эхинококкоза (гидатидоза)
Bogach et al. DETERMINATION OF THE CHRONIC TOXICITY PARAMETERS OF THE COMPLEX REMEDY FOR THE TREATMENT OF CYSTICERCOSIS IN RABBITS
RU2568869C1 (ru) Способ лечения демодекоза собак
RU2535068C1 (ru) Противогрибковый лекарственный препарат в суппозиториях для детей
RU2371187C1 (ru) Способ лечения паралича и эпилепсии у собак
RU2136303C1 (ru) Способ получения средства для лечения ларвального и стробилярного эхинококкозов "чеблин ск-1"
WO2005042015A1 (fr) Composition pharmaceutique anti-herpetique, procede de production d'une forme medicamenteuse a partir de cette composition et procede d'utilisation correspondant
WO2005067949A1 (fr) Preparation antivirale